WELL Health Technologies Corp.
Is WELL Health Technologies (WELL) halal?
WELL Health Technologies (TSX: WELL), the digital healthcare company, gets a FAIL: the clinics and health-tech business is clean, but C$628.7M of loans and borrowings is ~54% of market cap vs the ~33% ceiling.
Price chart by TradingView · Market data may be delayed · Shown for information only — not investment advice.
The two-gate Shariah screen
Every screener on this site runs the same two gates: first, the business must be halal (no conventional insurance, banking, alcohol, gambling, weapons manufacturing, and the like); second, the financial ratios must clear (debt under roughly 33% of market cap, non-compliant income under roughly 5%).
Gate one: the business — PASSED
WELL Health Technologies Corp. (TSX: WELL) is a digital healthcare company operating 275 clinics across Canada, US patient and provider services (including CRH Medical and Circle Medical), and health-technology businesses under WELLSTAR (electronic medical records, AI clinical tools, patient engagement). Q2 2026 revenue was C$400.4 million, up 12% year over year (company Q2 2026 results release, August 6, 2026). None of the standard AAOIFI prohibited business activities (conventional banking and insurance, alcohol, gambling, weapons, pork, tobacco, adult entertainment) are part of WELL's operations, so the business-activity gate passes. Facts only, no fatwa.
Gate two: the ratios — FAILED
Total loans and borrowings were C$628.7 million at June 30, 2026 (per Q2 2026 earnings call reporting), after the company drew on its expanded senior secured credit facility to fund acquisitions including the OID Group and UnionMD. Against a market capitalization of about C$1,155 million (C$4.41 per Finnhub, September 2026), that is roughly 54% debt-to-market-cap — well above the ~33% ceiling, so the ratios gate fails. Convertible debentures maturing in December 2026 (to be repaid from the C$150 million of 6.875% senior unsecured notes due 2031 issued July 15, 2026) and lease liabilities sit on top of the C$628.7 million figure. Cash of C$130.6 million at June 30, 2026 is about 11% of market cap. Interest (non-compliant) income was C$0.587 million on revenue of C$368.261 million in Q1 2026 — about 0.2%, under the ~5% ceiling — but it is moot because the debt gate already fails. All figures recomputed from the cited sources; WELL reports in Canadian dollars.
What other screeners say
At screening time (September 29, 2026), no current public Shariah rating for WELL Health was found on the Zoya, Musaffa, or ShariaPortfolio public pages — honestly reported as absent rather than invented. The FAIL recorded here rests on the debt ratio computed from the company's own reporting.
The bottom line
WELL Health Technologies (WELL) is a FAIL: the digital-healthcare business clears the activity gate, but total loans and borrowings of C$628.7 million at June 30, 2026 are roughly 54% of its market capitalization, well above the ~33% ceiling — before counting convertible debentures and lease liabilities. As with every screener here, this is a rules-based screening of published figures, not a religious ruling — consult a qualified scholar for personal guidance.
BDS screen
Whether this company appears on boycott, divestment and sanctions (BDS) lists. Informational only — it does not change the Shariah screening result above, and it is not a religious ruling.
No BDS listing found on the BDS movement's published boycott, divestment, or pressure lists (checked October 2026).
Moral screen
Beyond the Shariah financial gates, this checks the company’s documented business ties to the Israeli and US militaries, and to weapons manufacturing. Every finding is factual and sourced. A row with no finding means none surfaced in our review — not proof of none.
- Israeli military business
- No findings published.
- US military business
- No findings published.
- Weapons manufacturing & arms trade
- No findings published.
Halal alternatives in this sector
WELL did not pass the screen. These companies in the same sector passed:
- Cipher Pharmaceuticals Inc. PASS
- Extendicare Inc. PASS
- Knight Therapeutics Inc. PASS
Sources
- WELL Health Q2 2026 results press release (Aug 6, 2026)
- WELL Q2 2026 earnings call summary - debt/cash figures (stockinvest.us)
- WELL Q1 2026 interim financial statements - net finance cost note (quartr mirror)
- WELL market data (Finnhub, September 2026)
Frequently asked questions
Is WELL Health Technologies stock halal?
Based on this screener's AAOIFI-style checks, WELL Health gets a FAIL. Its digital-healthcare business clears the activity gate, but total loans and borrowings of C$628.7 million at June 30, 2026 are about 54% of its market capitalization, versus the ~33% ceiling. This is a screening result, not investment advice or a religious ruling.
How much debt does WELL Health have relative to its market value?
About 54%: total loans and borrowings of C$628.7 million at June 30, 2026 (per Q2 2026 earnings call reporting) divided by a market capitalization of about C$1,155 million (Finnhub, September 2026). Convertible debentures maturing December 2026 and lease liabilities are additional, so the all-in figure is higher.
Does WELL Health earn interest income?
A small amount: C$0.587 million of interest income on C$368.261 million of revenue in Q1 2026, about 0.2% - under the ~5% ceiling. The income gate is moot because the debt gate already fails.
What does WELL Health do?
WELL Health Technologies Corp. (TSX: WELL) is a digital healthcare company operating 275 clinics across Canada, US patient and provider services (including CRH Medical and Circle Medical), and health-technology businesses under WELLSTAR. Q2 2026 revenue was C$400.4 million.
Do Zoya, Musaffa, or ShariaPortfolio rate WELL Health?
No public rating from Zoya, Musaffa, or ShariaPortfolio was found for WELL Health as of September 2026, so this page relies on the company's own filings and market data instead.
Screened with our two-gate Shariah screening methodology (business-activity gate, then AAOIFI-style financial ratios).